ReNEW Clinic Cohort Study

Sponsor
Johns Hopkins University (Other)
Overall Status
Recruiting
CT.gov ID
NCT03816462
Collaborator
(none)
200
1
128
1.6

Study Details

Study Description

Brief Summary

This is an ongoing, prospective cohort study of children and young adults who are evaluated in the Reversing the Negative Effects of Weight on the Heart (ReNEW) Clinic at Johns Hopkins University.

Demographic and clinical data of patients who agree to participate are obtained via chart review and entered into a longitudinal clinic registry.

Study Design

Study Type:
Observational
Anticipated Enrollment :
200 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Reversing the Negative Cardiovascular Effects of Weight (ReNEW) Clinic Cohort Study
Actual Study Start Date :
Jan 1, 2015
Anticipated Primary Completion Date :
Sep 1, 2025
Anticipated Study Completion Date :
Sep 1, 2025

Outcome Measures

Primary Outcome Measures

  1. Demographic and clinical data obtained via chart review [5 years]

    This is a clinic based registry of cardiovascular disease risk data from participants to be collected over five years.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A to 22 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion criteria:
  • Children and young adults with overweight or obesity referred for evaluation of elevated blood pressure in the ReNEW Clinic at Johns Hopkins University are eligible.
Exclusion Criteria:
  • Children who are wards of the state or who are non-English speaking without an in-person interpreter accompanying them to the clinic visit.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Johns Hopkins University Baltimore Maryland United States 21287

Sponsors and Collaborators

  • Johns Hopkins University

Investigators

  • Principal Investigator: Tammy M Brady, Johns Hopkins University

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Johns Hopkins University
ClinicalTrials.gov Identifier:
NCT03816462
Other Study ID Numbers:
  • IRB00056175
First Posted:
Jan 25, 2019
Last Update Posted:
Jan 20, 2022
Last Verified:
Jan 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 20, 2022